146 related articles for article (PubMed ID: 29357902)
1. Intensity-modulated radiotherapy with integrated-boost in patients with bone metastasis of the spine: study protocol for a randomized controlled trial.
Sprave T; Welte SE; Bruckner T; Förster R; Bostel T; Schlampp I; Nicolay NH; Debus J; Rief H
Trials; 2018 Jan; 19(1):59. PubMed ID: 29357902
[TBL] [Abstract][Full Text] [Related]
2. High-dose single-fraction IMRT versus fractionated external beam radiotherapy for patients with spinal bone metastases: study protocol for a randomized controlled trial.
Rief H; Katayama S; Bruckner T; Rieken S; Bostel T; Förster R; Schlampp I; Wolf R; Debus J; Sterzing F
Trials; 2015 Jun; 16():264. PubMed ID: 26054533
[TBL] [Abstract][Full Text] [Related]
3. Pain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
Cellini F; Manfrida S; Deodato F; Cilla S; Maranzano E; Pergolizzi S; Arcidiacono F; Di Franco R; Pastore F; Muto M; Borzillo V; Donati CM; Siepe G; Parisi S; Salatino A; D'Agostino A; Montesi G; Santacaterina A; Fusco V; Santarelli M; Gambacorta MA; Corvò R; Morganti AG; Masiello V; Muto P; Valentini V
Trials; 2019 Oct; 20(1):609. PubMed ID: 31661034
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced toxicity after image-guided and intensity-modulated radiotherapy versus external beam radiotherapy for patients with spinal bone metastases (IRON-1): a study protocol for a randomized controlled pilot trial.
Meyerhof E; Sprave T; Welte SE; Nicolay NH; Förster R; Bostel T; Bruckner T; Schlampp I; Debus J; Rief H
Trials; 2017 Mar; 18(1):98. PubMed ID: 28253920
[TBL] [Abstract][Full Text] [Related]
5. Randomized phase II trial evaluating pain response in patients with spinal metastases following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; Nicolay NH; Debus J; Rief H
Radiother Oncol; 2018 Aug; 128(2):274-282. PubMed ID: 29843899
[TBL] [Abstract][Full Text] [Related]
6. A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
Gao LR; Wang X; Han W; Deng W; Li C; Wang X; Zhao Y; Ni W; Chang X; Zhou Z; Deng L; Wang W; Liu W; Liang J; Zhang T; Bi N; Wang J; Zhai Y; Feng Q; Lv J; Li L; Xiao Z
BMC Cancer; 2020 Sep; 20(1):901. PubMed ID: 32962674
[TBL] [Abstract][Full Text] [Related]
7. Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compression.
Murai T; Murata R; Manabe Y; Sugie C; Tamura T; Ito H; Miyoshi Y; Shibamoto Y
Pract Radiat Oncol; 2014; 4(6):e231-7. PubMed ID: 25407874
[TBL] [Abstract][Full Text] [Related]
8. Radiation-induced acute toxicities after image-guided intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for patients with spinal metastases (IRON-1 trial) : First results of a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Bruckner T; Bostel T; Welte SE; Tonndorf-Martini E; El Shafie R; Nicolay NH; Debus J; Rief H
Strahlenther Onkol; 2018 Oct; 194(10):911-920. PubMed ID: 29978307
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial.
Sahgal A; Myrehaug SD; Siva S; Masucci GL; Maralani PJ; Brundage M; Butler J; Chow E; Fehlings MG; Foote M; Gabos Z; Greenspoon J; Kerba M; Lee Y; Liu M; Liu SK; Thibault I; Wong RK; Hum M; Ding K; Parulekar WR;
Lancet Oncol; 2021 Jul; 22(7):1023-1033. PubMed ID: 34126044
[TBL] [Abstract][Full Text] [Related]
10. Bone density and pain response following intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for vertebral metastases - secondary results of a randomized trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
Radiat Oncol; 2018 Oct; 13(1):212. PubMed ID: 30376859
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
[TBL] [Abstract][Full Text] [Related]
12. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery.
Farooqi A; Bishop AJ; Narang S; Allen PK; Li J; McAleer MF; Tatsui CE; Rhines LD; Amini B; Wang XA; Ghia AJ
Pract Radiat Oncol; 2019 Mar; 9(2):e142-e148. PubMed ID: 30385151
[TBL] [Abstract][Full Text] [Related]
13. Intensity-modulated stereotactic radiotherapy of paraspinal tumors: a preliminary report.
Bilsky MH; Yamada Y; Yenice KM; Lovelock M; Hunt M; Gutin PH; Leibel SA
Neurosurgery; 2004 Apr; 54(4):823-30; discussion 830-1. PubMed ID: 15046647
[TBL] [Abstract][Full Text] [Related]
14. Quality of Life and Radiation-induced Late Toxicity Following Intensity-modulated
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie R; Nicolay NH; Debus J; Rief H
Anticancer Res; 2018 Aug; 38(8):4953-4960. PubMed ID: 30061275
[TBL] [Abstract][Full Text] [Related]
15. Effective local control of vertebral metastases by simultaneous integrated boost radiotherapy: preliminary results.
Lubgan D; Ziegaus A; Semrau S; Lambrecht U; Lettmaier S; Fietkau R
Strahlenther Onkol; 2015 Mar; 191(3):264-71. PubMed ID: 25395089
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation stereotactic body radiotherapy for spinal metastases: a multi-institutional outcome analysis.
Hashmi A; Guckenberger M; Kersh R; Gerszten PC; Mantel F; Grills IS; Flickinger JC; Shin JH; Fahim DK; Winey B; Oh K; John Cho BC; Létourneau D; Sheehan J; Sahgal A
J Neurosurg Spine; 2016 Nov; 25(5):646-653. PubMed ID: 27341054
[TBL] [Abstract][Full Text] [Related]
17. Imaging-Based Outcomes for 24 Gy in 2 Daily Fractions for Patients with de Novo Spinal Metastases Treated With Spine Stereotactic Body Radiation Therapy (SBRT).
Tseng CL; Soliman H; Myrehaug S; Lee YK; Ruschin M; Atenafu EG; Campbell M; Maralani P; Yang V; Yee A; Sahgal A
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):499-507. PubMed ID: 30003994
[TBL] [Abstract][Full Text] [Related]
18. Local response and pathologic fractures following stereotactic body radiotherapy versus three-dimensional conformal radiotherapy for spinal metastases - a randomized controlled trial.
Sprave T; Verma V; Förster R; Schlampp I; Hees K; Bruckner T; Bostel T; El Shafie RA; Welzel T; Nicolay NH; Debus J; Rief H
BMC Cancer; 2018 Aug; 18(1):859. PubMed ID: 30170568
[TBL] [Abstract][Full Text] [Related]
19. Volumetric Intensity-Modulated Arc Stereotactic Radiosurgery Boost in Oligometastatic Patients with Spine Metastases: a Dose-escalation Study.
Deodato F; Pezzulla D; Cilla S; Ferro M; Giannini R; Romano C; Boccardi M; Buwenge M; Valentini V; Morganti AG; Macchia G
Clin Oncol (R Coll Radiol); 2023 Jan; 35(1):e30-e39. PubMed ID: 36207236
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy for metastatic spinal cord compression with increased radiation doses (RAMSES-01): a prospective multicenter study.
Rades D; Hansen O; Jensen LH; Dziggel L; Staackmann C; Doemer C; Cacicedo J; Conde-Moreno AJ; Segedin B; Ciervide-Jurio R; Rubio-Rodriguez C; Perez-Romasanta LA; Alvarez-Gracia A; Dennis K; Ferrer-Albiach C; Navarro-Martin A; Lopez-Campos F; Jankarashvili N; Janssen S; Olbrich D; Holländer NH
BMC Cancer; 2019 Nov; 19(1):1163. PubMed ID: 31783816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
